Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, 98109, WA, USA.
Department of Oncology, The Johns Hopkins University School of Medicine, Baltimore, 21287, MD, USA.
Hum Pathol. 2022 Dec;130:18-24. doi: 10.1016/j.humpath.2022.10.010. Epub 2022 Oct 26.
Genomic studies have demonstrated a high level of intra-tumoral heterogeneity in prostate cancer. There is strong evidence suggesting that individual tumor foci can arise as genetically distinct, clonally independent lesions. However, recent studies have also demonstrated that adjacent Gleason pattern (GP) 3 and GP4 lesions can originate from the same clone but follow divergent genetic and morphologic evolution. The clonal relationship of adjacent GP3 and GP5 lesions has thus far not been investigated. Here we analyzed a cohort of 14 cases-11 biopsy and 3 radical prostatectomy specimens-with a Gleason score of 3 + 5 = 8 or 5 + 3 = 8 present in the same biopsy or in a single dominant tumor nodule at radical prostatectomy. Clonal and subclonal relationships between GP3 and GP5 lesions were assessed using genetically validated immunohistochemical assays for ERG, PTEN, and P53. 9/14 (64%) cases showed ERG reactivity in both GP3 and GP5 lesions. Only 1/14 (7%) cases showed a discordant pattern with ERG staining present only in GP3. PTEN expression was lost in 2/14 (14%) cases with perfect concordance between GP5 and GP3. P53 nuclear reactivity was present in 1/14 (7%) case in both GP5 and GP3. This study provides first evidence that the majority of adjacent GP3 and GP5 lesions share driver alterations and are clonally related. In addition, we observed a lower-than-expected rate of PTEN loss in GP5 in the context of Gleason score 3 + 5 = 8 or 5 + 3 = 8 tumors.
基因组研究表明,前列腺癌存在高度的肿瘤内异质性。有强有力的证据表明,个别肿瘤灶可以作为遗传上不同的、克隆性独立的病变出现。然而,最近的研究也表明,相邻的 Gleason 模式(GP)3 和 GP4 病变可以起源于同一个克隆,但遵循不同的遗传和形态进化。相邻 GP3 和 GP5 病变的克隆关系迄今为止尚未被研究过。在这里,我们分析了 14 例病例的队列,包括 11 例活检和 3 例根治性前列腺切除术标本,这些标本在同一活检或根治性前列腺切除术中的单个主要肿瘤结节中,均存在 Gleason 评分 3+5=8 或 5+3=8。使用经过基因验证的 ERG、PTEN 和 P53 免疫组织化学检测方法,评估了 GP3 和 GP5 病变之间的克隆和亚克隆关系。9/14(64%)例 GP3 和 GP5 病变均有 ERG 反应。仅有 1/14(7%)例显示 ERG 染色仅在 GP3 中存在的不一致模式。PTEN 表达缺失见于 2/14(14%)例,其中 GP5 和 GP3 完全一致。P53 核反应性存在于 1/14(7%)例 GP5 和 GP3 中。这项研究首次提供证据表明,大多数相邻的 GP3 和 GP5 病变具有驱动基因改变,并存在克隆相关性。此外,我们观察到在 Gleason 评分 3+5=8 或 5+3=8 肿瘤中,PTEN 缺失的比例低于预期。